✦ LIBER ✦

‘Who’, ‘when’ and ‘how’ in re-irradiation of recurrent painful bone metastases

✍ Scribed by Mok, Florence; Li, Kenneth; Yeung, Rebecca; Wong, Kam-Hung; Yu, Brian; Wong, Erin; Bedard, Gillian; Chow, Edward

Book ID: 122177498
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 154 KB
Volume: 2
Category: Article
ISSN: 2212-1374
DOI: 10.1016/j.jbo.2012.12.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Practical Considerations in the Re-Irrad

Practical Considerations in the Re-Irradiation of Recurrent and Second Primary Head-and-Neck Cancer: Who, Why, How, and How Much?

✍ Allen M. Chen; Theodore L. Phillips; Nancy Y. Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Response and Quality of Life (QOL) Outco

Response and Quality of Life (QOL) Outcomes in a Randomized Trial of Single Versus Multiple Fractions (Fx) for Re-irradiation (RE-RT) of Painful Bone Metastases (PBM): NCIC CTG SC.20

✍ Chow, E.; Van Der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Brunda 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Local irradiation in combination with be

Local irradiation in combination with bevacizumab enhances radiation control of bone destruction and cancer-induced pain in a model of bone metastases

✍ Pawel Zwolak; Arkadiusz Z. Dudek; Vidya D. Bodempudi; Julia Nguyen; Robert P. He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 314 KB

## Abstract Skeletal metastases are a major source of morbidity for cancer patients. The purpose of this study was to evaluate the effects of megavoltage irradiation and antiangiogenic therapy on metastatic bone cancer. A tumor xenograft model was prepared in C3H/Scid mice using 4T1 murine breast c

Re-irradiation in conjunction with lipos

Re-irradiation in conjunction with liposomal doxorubicin for the treatment of skin metastases of recurrent breast cancer: a radiobiological approach and 2 year of follow-up

✍ Vassilis E. Kouloulias; George A. Plataniotis; John R. Kouvaris; Costas E. Dardo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Safety and Efficacy of the Specific Endo

Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial

✍ Nicholas D. James; Armelle Caty; Michael Borre; Bernard A. Zonnenberg; Philippe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 1000 KB